Breast Cancer Clinical Trial

Massage Therapy in Treating the Symptoms of Patients With Locally Advanced or Metastatic Cancer

Summary

RATIONALE: Massage therapy may help relieve symptoms associated with cancer. It is not yet known which type of massage therapy is more effective in treating the symptoms of patients with cancer.

PURPOSE: This randomized clinical trial is studying different types of massage therapy to compare how well they work in treating the symptoms of patients with locally advanced or metastatic cancer.

View Full Description

Full Description

OBJECTIVES:

Compare the safety and tolerated dose (i.e., duration, techniques, and degree of pressure) of professional massage therapy vs professional simple presence (no touch) massage therapy vs usual care followed by caregiver massage therapy vs usual care in patients with locally advanced or metastatic cancer.
Correlate these therapies with pain, anxiety, depression, nausea, and shortness of breath in these patients.
Correlate these therapies with patient quality of life and caregiver anxiety and depression.
Determine the feasibility of teaching family caregivers how to provide massage therapy and the subsequent use of massage by the caregivers.
Determine the effects of caregiver massage therapy on patients and caregivers.
Determine the feasibility and acceptability among patients and massage therapists of a simple presence (no touch) massage therapy control group.

OUTLINE: This is a randomized, controlled, pilot study. Patients are randomized to 1 of 3 treatment arms.

Arm I (professional massage therapy): Hospitalized patients are offered massage therapy by a licensed massage therapist for 15-45 minutes once daily for the duration of their hospital stay. Outpatient oncology clinic patients are offered home-based massage therapy by a licensed massage therapist for 15-45 minutes once daily for 3 days.
Arm II (usual care): Patients receive usual care for symptom management.
Arm III (professional simple presence [no touch] massage therapy): Hospitalized patients are offered simple presence (no touch) massage therapy comprising a room visit by a licensed massage therapist who places his/her hands 12 inches over the patient without direct touch for 15-45 minutes. Treatment is offered once daily for the duration of the hospital stay. Outpatient oncology clinic patients are offered home-based simple presence (no touch) massage therapy by a licensed massage therapist for 15-45 minutes once daily for 3 days.

All patients are then randomized (a second time) to 1 of 2 treatment arms.

Arm I (caregiver massage therapy): Previously hospitalized patients are offered home-based caregiver massage therapy for 1 month. Outpatient oncology clinic patients are offered home-based caregiver massage therapy for 3 weeks.
Arm II (usual care): Patients receive usual care for symptom management. Hospitalized patients complete a questionnaire addressing symptoms, quality of life, satisfaction with symptom control, and time spent up or out of bed once daily on days 1-5, every 3 days while in the hospital, and then at 1 week, 2 weeks, and 1 month after discharge from the hospital. Outpatient oncology clinic patients complete a similar telephone questionnaire at baseline, 1 week, and then at 1 month.

PROJECTED ACCRUAL: Approximately 100 patients will be accrued for this study.

View Eligibility Criteria

Eligibility Criteria

Inclusion criteria:

Solid cancer with evidence of metastases
Receiving treatment at Beth Israel Deaconess Medical Center (BIDMC)
Must reside ≤ 25 miles from BIDMC

Exclusion criteria:

Patient to sick to be interviewed
Absence of severe symptoms
Participating in another trial
Language barrier
MD does not provide permission
Expired prior to consent process

Study is for people with:

Breast Cancer

Estimated Enrollment:

39

Study ID:

NCT00253708

Recruitment Status:

Completed

Sponsor:

Beth Israel Deaconess Medical Center

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Beth Israel Deaconess Medical Center
Boston Massachusetts, 02215, United States

How clear is this clinincal trial information?

Study is for people with:

Breast Cancer

Estimated Enrollment:

39

Study ID:

NCT00253708

Recruitment Status:

Completed

Sponsor:


Beth Israel Deaconess Medical Center

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider